Skip to content

DS-DNA EIA Diagnostic Kit

by Biohytech International, Inc.

510(k) K870453

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK870453 Date24 Mar 1987ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
LJM
Device Class
Class II
Regulation
21 CFR Part 866.5100
Advisory Committee
Immunology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The DS-DNA EIA Diagnostic Kit is an enzyme immunoassay (EIA) device used for the detection of double-stranded DNA (dsDNA) antibodies. It is classified as an antinuclear antibody test and is intended for use in immunology testing.

The device is supplied as a diagnostic kit and is intended for in vitro diagnostic use. It received FDA 510(k) clearance (K870453) on March 24, 1987, and is regulated as a Class II medical device under regulation number 866.5100 with product code LJM.

Other devices from Biohytech International, Inc.

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the DS-DNA EIA Diagnostic Kit used for?

    The DS-DNA EIA Diagnostic Kit is an enzyme immunoassay device used for the detection of double-stranded DNA (dsDNA) antibodies. It is classified as an antinuclear antibody test and is intended for use in immunology testing for in vitro diagnostic purposes.

  • How is the DS-DNA EIA Diagnostic Kit supplied and what is its intended use?

    The device is supplied as a diagnostic kit and is intended for in vitro diagnostic use. It is designed for laboratory testing to detect dsDNA antibodies in patient samples as part of immunology assessments.

  • What regulatory pathway was used for the DS-DNA EIA Diagnostic Kit and what is its classification?

    The DS-DNA EIA Diagnostic Kit received FDA 510(k) clearance (K870453) on March 24, 1987, through a traditional submission. It is regulated as a Class II medical device under regulation number 866.5100 with product code LJM.

  • What does the FDA 510(k) clearance K870453 indicate about the DS-DNA EIA Diagnostic Kit?

    The FDA 510(k) clearance K870453 indicates that the DS-DNA EIA Diagnostic Kit was found substantially equivalent to a legally marketed predicate device. The decision description is 'Substantially Equivalent' and it was cleared via a traditional 510(k) pathway.

  • Is the DS-DNA EIA Diagnostic Kit intended for reuse or single-use applications?

    The device data does not specify whether the DS-DNA EIA Diagnostic Kit is intended for single-use or reuse. As a diagnostic kit containing reagents and controls, it is typically designed for single-use testing runs, but reuse characteristics must be determined from the product labeling or manufacturer’s instructions, which are not provided in the data.